An Historic Perspective of Proteasome InhibitionESSELTINE, Dixie-Lee; MULLIGAN, George.Seminars in hematology. 2012, Vol 49, Num 3, pp 196-206, issn 0037-1963, 11 p.Article

Discovery and Development of Second-Generation Proteasome InhibitorsKIRK, Christopher J.Seminars in hematology. 2012, Vol 49, Num 3, pp 207-214, issn 0037-1963, 8 p.Article

Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome InhibitionEVERLY, Matthew J; TERASAKI, Paul I; HOPFIELD, Judy et al.Transplantation. 2010, Vol 90, Num 12, pp 1493-1498, issn 0041-1337, 6 p.Conference Paper

Proteasome Inhibitors as Immunosuppressants: Biological Rationale and Clinical ExperienceMORAN, Eva; CARBONE, Federico; AUGUSTI, Valeria et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 270-276, issn 0037-1963, 7 p.Article

Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5α B-box 2 domainDIAZ-GRIFFERO, Felipe; KAR, Alak; PERRON, Michel et al.Journal of virology. 2007, Vol 81, Num 19, pp 10362-10378, issn 0022-538X, 17 p.Article

Durability of Antibody Removal Following Proteasome Inhibitor-Based TherapyEVERLY, Matthew J; TERASAKI, Paul I; TRIVEDI, Hargovind L et al.Transplantation. 2012, Vol 93, Num 6, pp 572-577, issn 0041-1337, 6 p.Article

Proteasome Inhibitors in Cancer Therapy : Lessons from the First Decade : The development of new cytotoxic agents in clinical oncologyORLOWSKI, Robert Z; KUHN, Deborah J.Clinical cancer research. 2008, Vol 14, Num 6, pp 1649-1657, issn 1078-0432, 9 p.Article

The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In VivoDIWAN, Tayyab S; RAGHAVAIAH, Suresh; BURNS, Justin M et al.Transplantation. 2011, Vol 91, Num 5, pp 536-541, issn 0041-1337, 6 p.Article

Gα_12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulationYOON MEE YANG; LEE, Sanghwan; CHANG WON NAM et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 7, pp 1230-1237, issn 0143-3334, 8 p.Article

The Proteasome Inhibitor Epoxomicin Has Potent Plasmodium falciparum Gametocytocidal ActivityCZESNY, Beata; GOSHU, Samrawit; COOK, James L et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 10, pp 4080-4085, issn 0066-4804, 6 p.Article

Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cellsMURAKAWA, Yasuhiro; SONODA, Eiichiro; BOULTON, Simon J et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8536-8543, issn 0008-5472, 8 p.Article

Proteasome Inhibition for Antibody-Mediated Allograft RejectionSADAKA, Basma; ALLOWAY, Rita R; SHIELDS, Adele R et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 263-269, issn 0037-1963, 7 p.Article

Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cellsTAKEZAWA, Jun; ISHIMI, Yukio; YAMADA, Kouichi et al.Cancer science. 2008, Vol 99, Num 5, pp 863-871, issn 1347-9032, 9 p.Article

Downregulation of MMP-2 and -9 by Proteasome Inhibition : A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular OpacificationAWASTHI, Niranjan; WANG-SU, Shuh Tuan; WAGNER, B. J et al.Investigative ophthalmology & visual science. 2008, Vol 49, Num 5, pp 1998-2003, issn 0146-0404, 6 p.Article

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapyDICK, Lawrence R; FLEMING, Paul E.Drug discovery today. 2010, Vol 15, Num 5-6, pp 243-249, issn 1359-6446, 7 p.Article

A mechanistic and kinetic study of the p-lactone hydrolysis of salinosporamide A (NPI-0052), a novel proteasome inhibitorDENORA, Nunzio; POTTS, Barbara C. M; STELLA, Valentino J et al.Journal of pharmaceutical sciences. 2007, Vol 96, Num 8, pp 2037-2047, issn 0022-3549, 11 p.Article

Role of Intracellular Calcium in Proteasome Inhibitor-Induced Endoplasmic Reticulum Stress, Autophagy, and Cell Death : Disease, Drug Metabolism, and Transporter InteractionsWILLIAMS, Jessica A; YIFENG HOU; NI, Hong-Min et al.Pharmaceutical research. 2013, Vol 30, Num 9, pp 2279-2289, issn 0724-8741, 11 p.Article

Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment StrategyWRIGHT, John J.Clinical cancer research (Print). 2010, Vol 16, Num 16, pp 4094-4104, issn 1078-0432, 11 p.Article

Selective proteasome inhibitors may provide a novel therapeutic approach to Mycobacterium tuberculosisMAHENDRAN, S.Thorax. 2010, Vol 65, Num 4, issn 0040-6376, p. 285Article

Can Tumor Growth Be Further Inhibited by Combining Drugs Such as Bortezomib with Image-guided Interventional Oncologic Procedures?NAHUM GOLDBERG, S.Radiology. 2008, Vol 248, Num 2, pp 323-325, issn 0033-8419, 3 p.Article

The value of proteasome inhibition in cancerCVEK, Boris; DVORAK, Zdenek.Drug discovery today. 2008, Vol 13, Num 15-16, pp 716-722, issn 1359-6446, 7 p.Article

Proteasome inhibition leads to dephosphorylation and downregulation of protein expression of members of the Akt/mTOR pathway in MCLHUTTER, G; ZIMMERMANN, Y; RIEKEN, M et al.Leukemia. 2012, Vol 26, Num 11, pp 2442-2444, issn 0887-6924, 3 p.Article

Gap junctions sensitize cancer cells to proteasome inhibitor MG132-induced apoptosisTAO HUANG; YING ZHU; XIN FANG et al.Cancer science. 2010, Vol 101, Num 3, pp 713-721, issn 1347-9032, 9 p.Article

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade)ARPINATI, M; CHIRUMBOLO, G; NICOLINI, B et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 3, pp 253-259, issn 0268-3369, 7 p.Article

Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection : role of nuclear factor-κBLA FRAZIA, Simone; AMICI, Carla; SANTORO, M. Gabriella et al.Antiviral therapy (London). 2006, Vol 11, Num 8, pp 995-1004, issn 1359-6535, 10 p.Article